Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement

6/3/2022

A breakthrough achievement published in Life Sciences, featured in Medicine Innovates platform, is an outcome of a wholesome ecosystem in Japan, value adding to the inter-disciplinary research of GN Corp through a network of international collaborators.

Please visit the article of Medicine Innovates.

Other News

専門誌 Annals of Epidemiology & Public Health に論文発表

Value addition to Japanese technologies by GN Corp, featured in Government of Japan official website

10/5/2022

GNC’s activities are introduced in the Japan Cabinet Office’s site ‘Invest Japan’

A study of Nichi Glucan on children with autism has been published in Research Features Magazine

10/5/2022

This is the research on the potential of beta-glucan for autism

CHINA BIO、 BIO PHAMA AMERICA、 BIO EUROPEへ参加します

Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement

6/3/2022

A breakthrough achievement on miRNA140 is published in Medicine Innovates

GN Corp track record published in Bloomberg

6/3/2022

An interview was published in a feature story in Bloomburg

BEES-HAUS method yielding successful cell engraftment to prevent recurrence of urethral stricture confirmed; Manuscript published in Stem Cell Reviews and Reports

26/11/2022

Manuscript published in Stem Cell Reviews and Reports

Autologous immune-cell therapy practiced in Japan, helping Vinmec Hospital after technology transfer

16/10/2022

Technology transfer on cell therapy to Vietnam by GN Corporation leads to new opportunities

Webiner on “Cell Therapy Approaches for Urethral Stricture” jointly held with Edogawa Hospital

1/10/2022

Webiner on Cell Therapy Approaches for Urethral Stricture is held on 16 OCt 2022

Paper on Potential of Beta-Glucan Products to Prevent and Treat Non-Alcoholic Fatty Liver Disease

1/10/2022

A look at the potential of beta-glucan for the growing number of non-alcoholic fatty liver diseases

Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement

Other News

Value addition to Japanese technologies by GN Corp, featured in Government of Japan official website

A study of Nichi Glucan on children with autism has been published in Research Features Magazine

Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement

GN Corp track record published in Bloomberg

Other articles

BEES-HAUS method yielding successful cell engraftment to prevent recurrence of urethral stricture confirmed; Manuscript published in Stem Cell Reviews and Reports

Autologous immune-cell therapy practiced in Japan, helping Vinmec Hospital after technology transfer

Webiner on “Cell Therapy Approaches for Urethral Stricture” jointly held with Edogawa Hospital

Paper on Potential of Beta-Glucan Products to Prevent and Treat Non-Alcoholic Fatty Liver Disease

© 2022GN Corporation All Rights Reserved

Nichi Glucan Online Shop